胃癌是全球最常见的消化道恶性肿瘤之一,我国近一半的胃癌患者在确诊时已处于晚期,HER2是晚期胃癌诊疗最常见的靶点之一,临床研究已证明抗HER2靶向治疗能够带来显著的生存获益。2025年欧洲肿瘤内科学会年会(ESMO 2025)于10月17日至21日在德国柏林盛大召开,本次大会公布了Ⅲ期KC-WISE研究的最新结果,惊艳数据引发会场专家纷纷起立鼓掌,该研究或可为建立标准且有效的HER2高表达晚期胃癌...
Source Link胃癌是全球最常见的消化道恶性肿瘤之一,我国近一半的胃癌患者在确诊时已处于晚期,HER2是晚期胃癌诊疗最常见的靶点之一,临床研究已证明抗HER2靶向治疗能够带来显著的生存获益。2025年欧洲肿瘤内科学会年会(ESMO 2025)于10月17日至21日在德国柏林盛大召开,本次大会公布了Ⅲ期KC-WISE研究的最新结果,惊艳数据引发会场专家纷纷起立鼓掌,该研究或可为建立标准且有效的HER2高表达晚期胃癌...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.